MUC16 and neoplasm: Another factor relating to better therapy response in HPV(+) tumors could be that HPV(−) exosomes are enriched in tumor-promoting and immunosuppressive proteins such as MUC-1, HLA-DRA, MUC-4, and MUC-16, which give protection to tumor cells against NK cell-mediated lysis.